Lohith Gowda

1.0k total citations · 1 hit paper
35 papers, 439 citations indexed

About

Lohith Gowda is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Lohith Gowda has authored 35 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Oncology and 11 papers in Genetics. Recurrent topics in Lohith Gowda's work include Acute Myeloid Leukemia Research (9 papers), CAR-T cell therapy research (8 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Lohith Gowda is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), CAR-T cell therapy research (8 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Lohith Gowda collaborates with scholars based in United States, India and United Arab Emirates. Lohith Gowda's co-authors include Amer M. Zeidan, Roy F. Chemaly, Andrew St. Martin, Marcie Riches, Muhammad Bilal Abid, Gunjan L. Shah, Neel S. Bhatt, Miguel‐Angel Perales, Akshay Sharma and Jenni Bloomquist and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Genetics.

In The Last Decade

Lohith Gowda

31 papers receiving 436 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

2021 202 citations Akshay Sharma, Neel S. Bhatt et al. The Lancet Haematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lohith Gowda United States	11	186	178	166	67	61	35	439
Marcie Riches United States	9	209 1.1×	211 1.2×	263 1.6×	118 1.8×	73 1.2×	43	555
Odelia Amit Israel	13	278 1.5×	97 0.5×	167 1.0×	59 0.9×	92 1.5×	39	525
Amandine Le Bourgeois France	12	166 0.9×	130 0.7×	220 1.3×	161 2.4×	37 0.6×	62	437
Ayumu Ito Japan	12	163 0.9×	100 0.6×	98 0.6×	129 1.9×	110 1.8×	50	438
L. S. Zubarovskaya Russia	9	62 0.3×	78 0.4×	126 0.8×	49 0.7×	53 0.9×	140	297
Noa Lavi Israel	16	200 1.1×	94 0.5×	258 1.6×	61 0.9×	214 3.5×	58	603
Kamille A. West United States	13	159 0.9×	111 0.6×	124 0.7×	64 1.0×	71 1.2×	43	480
Sigrun Einarsdottir Sweden	9	141 0.8×	160 0.9×	110 0.7×	115 1.7×	15 0.2×	22	438
Akihito Shinohara Japan	13	104 0.6×	104 0.6×	221 1.3×	62 0.9×	65 1.1×	43	493
Lucrecia Yáñez Spain	12	237 1.3×	47 0.3×	82 0.5×	84 1.3×	93 1.5×	40	467

Countries citing papers authored by Lohith Gowda

Since Specialization

Citations

This map shows the geographic impact of Lohith Gowda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lohith Gowda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lohith Gowda more than expected).

Fields of papers citing papers by Lohith Gowda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lohith Gowda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lohith Gowda. The network helps show where Lohith Gowda may publish in the future.

Co-authorship network of co-authors of Lohith Gowda

This figure shows the co-authorship network connecting the top 25 collaborators of Lohith Gowda. A scholar is included among the top collaborators of Lohith Gowda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lohith Gowda. Lohith Gowda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malki, Monzr M. Al, Alla Keyzner, Yibin Chen, et al.. (2025). TSC-100 and TSC-101 Demonstrate the Potential to Reduce Relapse Rates and Increase Relapse-Free Survival in Patients with AML, ALL, or MDS Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) with Reduced Intensity Conditioning (RIC): Preliminary Results from the Phase 1 Alloha Trial (NCT05473910). Transplantation and Cellular Therapy. 31(2). S59–S60.

Biavasco, Francesca, Johannes Clausen, Johannes Jung, et al.. (2025). Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey. Bone Marrow Transplantation. 60(6). 873–878.

Malki, Monzr M. Al, Alla Keyzner, Hyung C. Suh, et al.. (2024). A phase 1 trial of TSC-100 and TSC-101, engineered T cell therapies that target minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation.. Journal of Clinical Oncology. 42(16_suppl). TPS2678–TPS2678. 1 indexed citations

Gulbis, Alison, Tao Wang, Catherine J. Lee, et al.. (2024). Incidence of bacterial blood stream infections in patients with acute GVHD. Bone Marrow Transplantation. 60(1). 52–57. 1 indexed citations

Ali, Alaa M., Nausheen Ahmed, Soyoung Kim, et al.. (2024). Real World Comparison of Efficacy and Safety of Fludarabine-Versus Bendamustine-Based Lymphodepleting Chemotherapy for CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Relapse/Refractory (r/r) Large B-Cell Lymphoma (LBCL). Blood. 144(Supplement 1). 71–71.

Üstün, Celalettin, Min Chen, Soyoung Kim, et al.. (2023). Post-transplantation cyclophosphamide is associated with increased bacterial infections. Bone Marrow Transplantation. 59(1). 76–84. 4 indexed citations

Murthy, Guru Subramanian Guru, Brent R. Logan, Amer Beitinjaneh, et al.. (2023). Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia. American Journal of Hematology. 98(4). 608–619. 10 indexed citations

Kim, Dongjoo, Giulia Biancon, Zhiliang Bai, et al.. (2023). Microfluidic Immuno‐Serolomic Assay Reveals Systems Level Association with COVID‐19 Pathology and Vaccine Protection. Small Methods. 7(10). e2300594–e2300594. 4 indexed citations

Di, Mengyang, Iris Isufi, Lohith Gowda, et al.. (2022). Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma. Blood Advances. 7(5). 801–810. 38 indexed citations

10.

Gowda, Lohith, Sunitha Vege, Debra Kessler, Beth H. Shaz, & Connie M. Westhoff. (2021). Screening of blood donors for sickle cell trait using a DNA‐based approach: Frequency in a multiethnic donor population. Transfusion. 61(7). 2008–2013. 6 indexed citations

11.

Bewersdorf, Jan Philipp, Abu‐Sayeef Mirza, Alyssa Grimshaw, et al.. (2021). Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation–A Systematic Review and Meta-Analysis. Transplantation and Cellular Therapy. 27(12). 997.e1–997.e11. 23 indexed citations

12.

Bewersdorf, Jan Philipp, Amar H. Sheth, Alyssa Grimshaw, et al.. (2021). Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis—A Systematic Review and Meta-Analysis. Transplantation and Cellular Therapy. 27(10). 873.e1–873.e13. 10 indexed citations

13.

Sharma, Akshay, Neel S. Bhatt, Andrew St. Martin, et al.. (2021). Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. The Lancet Haematology. 8(3). e185–e193. 202 indexed citations breakdown →

14.

Foss, Francine M., Ami N. Rubinowitz, Marie L. Landry, et al.. (2020). Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib. Clinical Lymphoma Myeloma & Leukemia. 20(11). 720–723. 8 indexed citations

15.

Shallis, Rory M., Nikolai A. Podoltsev, Lohith Gowda, Amer M. Zeidan, & Steven D. Gore. (2020). Cui bono?Finding the value of allogeneic stem cell transplantation for lower-risk myelodysplastic syndromes. Expert Review of Hematology. 13(5). 447–460. 2 indexed citations

16.

Ghobadi, Armin, Denái R. Milton, Lohith Gowda, et al.. (2019). HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant. Current Research in Translational Medicine. 67(2). 51–55. 12 indexed citations

17.

McManus, Dayna, Noffar Bar, Francine M. Foss, et al.. (2019). The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN). Transplant Infectious Disease. 21(2). e13059–e13059. 5 indexed citations

18.

Gowda, Lohith, Mithun Vinod Shah, Qaiser Bashir, et al.. (2018). Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs. Bone Marrow Transplantation. 54(7). 1089–1093. 17 indexed citations

19.

Gowda, Lohith & Francine M. Foss. (2018). Hepatosplenic T-Cell Lymphomas. Cancer treatment and research. 176. 185–193. 3 indexed citations

20.

Gowda, Lohith, et al.. (1979). POPULATION GENETICS OF DROSOPHILA NASUTA NASUTA, DROSOPHILA NASUTA ALBOMICANA AND THEIR HYBRIDS. I. KARYOTYPIC MOSAICISM IN THE HYBRID POPULATIONS. Genetics. 93(1). 211–215. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact